Chronic Respiratory Disease
Chronic Respiratory Diseases (CRD). Diseases of the airways and other lung and lung structures. Chronic obstructive pulmonary disease (COPD), asthma, occupational lung disease and pulmonary hypertension are the most common. In addition to tobacco smoke, other risk factors include air pollution, occupational chemicals and dust and frequent respiratory infections in childhood. CRDs cannot be cured, however, as a variety of treatments can help narrow the airways and improve breathing, which can help control symptoms and raise living standards for those with the disease. As FSF-IHCE , we focus In a world where people breathe freely, GARD focuses specifically on the needs of those with CRD in low-income and middle-income countries.
Chronic Respiratory Diseases Chronic diseases of the airways and other lung and lung structures. Two of the most common are asthma and chronic obstructive pulmonary disease (COPD).
Asthma is a chronic, non-communicable disease characterized by recurrent attacks of shortness of breath and shortness of breath that vary in severity and frequency from person to person. Symptoms appear several times a day or week in affected individuals and some may worsen during physical activity or at night. Asthma is a very common chronic disease in children.
COPD is not a single disease, but an umbrella term used to describe chronic lung lung disease that causes a restriction in the air flow to the lungs. The most common symptoms of COPD are shortness of breath, or ‘need for air’, excessive sputum production and chronic cough.
Risk factors for chronic respiratory diseases include tobacco smoking (including second-hand smoke), air pollution, allergies and professional exposure. Outdoor air pollution and indoor air pollution (often caused by cooking with solid fuels) are also common causes. List of tobacco companies
Smoking and Covid-19
Smoking is a risk factor for many diseases. COVID-19 has its own new classroom. Many countries have just begun to say that smokers are 14 times more likely to die from COVID-19, but few have issued a warning to quit smoking and, to our knowledge, no country has controlled tobacco control measures. In the wake of this epidemic, we do not know of any country that has widely distributed free nicotine replacement therapy or retirement auxiliary drugs, yet many countries have implemented a “financial aid package” and less developed countries are at risk of disaster.
However, in its seventh update on COVID-19, the European Center for Disease Prevention and Control (ECDC) recently suggested that critical determinants of COVID-19 be identified, such as smoking and drugs. The number of serious cases and the efficiency of the hospital will be affected.
FSF-IHCE aims to support member states in their efforts to reduce the incidence of chronic respiratory illness, disability and premature death, and especially asthma and chronic obstructive pulmonary disease.